The Middle East & Africa smart pills market is expected to reach US$ 227.44 million by 2028 from US$ 110.93 million in 2021. The market is estimated to grow at a CAGR of 10.8% from 2021 to 2028.
The demand for drug delivery systems with fundamental benefits, such as minimal side/adverse effects, targeted drug delivery, optimal use of API, and reduced dosage frequency, has witnessed a surge. This has further resulted in integrating innovative drugs, advanced technologies, and medical devices into drug delivery systems to develop smart pills. People suffering from chronic diseases who need a specific dose of medication are likely to target the patient base for smart pills.
The companies have offered various promotional activities, such as product launch, investment, and acquisitions, for instance: In 2019, Otsuka (Proteus) launched smart chemotherapy pills to improve cancer patients' outcomes. In 2019, Stanley Black & Decker and Pillo Health launched a pill-dispensing robot companion. It has been designed to help patients with chronic conditions maintain their medication schedule and health with the help of a built-in voice assistant to communicate with caregivers and patients. Smart pills technologies provide revolutionary advancements for life science research applications. Thus, increasing demand for drug delivery systems in emerging economies is likely to increase the growth of the smart pills market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the smart pills market. The Middle East & Africa smart pills market is expected to grow at a good CAGR during the forecast period.
Middle East & Africa Smart Pills Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Smart Pills Market Segmentation
The Middle East & Africa smart pills market is segmented based on application, disease indication, and end user. Based on application, the market is segmented into capsule endoscopy, drug delivery, and patient monitoring. The capsule endoscopy segment is sub segmented into small bowel video capsule endoscopy, colon capsule endoscopy, controllable capsule endoscopy, storable capsule endoscopy, and other capsule endoscopy. Based on disease indication, the market is segmented into gastrointestinal diseases, neurological disorders, cancer, inherited disorders, and other disease indications. Based on end user, the market is segmented into hospitals and clinics, research institutes, and home healthcare. By Country, the Middle East & Africa smart pills market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of MEA.
Middle East & Africa Smart Pills Market – Companies Mentioned
Medtronic; Check-Cap ; PENTAX Medical; Olympus Corporation ;and Otsuka Holdings Co., Ltd. ;are among the leading companies in the Middle East & Africa smart pills market.
Middle East & Africa Smart Pills Market Strategic Insights
Middle East & Africa Smart Pills Market Report Highlights
| Report Attribute | Details |
| Market size in 2021 | US$ 110.93 Million |
| Market Size by 2028 | US$ 227.44 Million |
| CAGR (2021 - 2028) | 10.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Application
|
|
Regions and Countries Covered
|
|
| Middle East and Africa | South Africa, Saudi Arabia, UAE, Rest of Middle East and Africa |
| Market leaders and key company profiles |
|
Middle East & Africa Smart Pills Market Country and Regional Insights
